U.S., Aug. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07766161) titled 'Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression' on Aug. 05.
Brief Summary: The proposed study is an open-label trial of Re-Timer(R) wearable morning bright light therapy for postpartum depression. The study is focused on evaluating the feasibility, acceptability, and implementation context of morning Bright Light Treatment (mBLT) for postpartum depression.
Study Start Date: July 29
Study Type: INTERVENTIONAL
Condition:
Postpartum Depression (PPD)
Intervention:
DEVICE: Light therapy
Participants will use the Re-Timer daily for 5 weeks (approximately 35 days). All participants will be pro...